Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1158/2159-8290.CD-15-0352 http://scihub22266oqcxt.onion/10.1158/2159-8290.CD-15-0352 C4422076!4422076 !25941336     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25941336 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Cancer+Discov 2015 ; 5 (5 ): 466-8 Nephropedia Template TP {{tp|p=25941336 |t=2015. RAI2: Linking Retinoic Acid Signaling with Metastasis Suppression |pdf=|usr=}}{{25941336 }} gab.com Text RAI2: Linking Retinoic Acid Signaling with Metastasis Suppression JO: Cancer Discov http://www.kidney.de/pget.php?&tw=1&pmid=25941336 #FOAvip Considerable evidence points to the importance of disseminated tumor cells, which are commonly detected in the bone marrow and display features of cellular plasticity, in predicting the clinical outcome of breast cancer. In this issue of Cancer Discovery, Werner and colleagues report on the discovery of retinoic acid-induced 2 (RAI2) as a differentiation factor that suppresses early metastatic spread of estrogen receptor-positive breast cancer. Twit Text FOAVip RAI2: Linking Retinoic Acid Signaling with Metastasis Suppression ????Cancer Discov http://www.kidney.de/pget.php?&tw=1&pmid=25941336 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25941336 #FOAvip English Wikipedia <ref>{{Cite pmid|25941336 }}</ref> RAI2: Linking Retinoic Acid Signaling with Metastasis Suppression #MMPMID25941336 Esposito M ; Kang Y Cancer Discov 2015[May]; 5 (5 ): 466-8 PMID25941336 show ga Considerable evidence points to the importance of disseminated tumor cells, which are commonly detected in the bone marrow and display features of cellular plasticity, in predicting the clinical outcome of breast cancer. In this issue of Cancer Discovery, Werner and colleagues report on the discovery of retinoic acid-induced 2 (RAI2) as a differentiation factor that suppresses early metastatic spread of estrogen receptor-positive breast cancer. |Bone Marrow/*pathology [MESH] |Breast Neoplasms/*genetics/*pathology [MESH] |Female [MESH] |Humans [MESH] |Intercellular Signaling Peptides and Proteins [MESH] |Neoplastic Cells, Circulating/*pathology [MESH]RAI2: Linking Retinoic Acid Signaling with Metastasis Suppression (epmc).pdf DeepDyve Pubget Overpricing